✦ LIBER ✦

A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK

✍ Scribed by Karin Bruynesteyn; Vanya Gant; Catherine McKenzie; Tony Pagliuca; Chris Poynton; Ritesh N. Kumar; Jeroen P. Jansen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic evaluation of caspofungin vs li

✍ Peter Kaskel; Silja Tuschy; Alexander Wagner; Christian Bannert; Oliver A. Corne 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 202 KB

PIN68 Cost-Minimization Analysis of Casp

✍ M. Charokopou; I.M. Majer; J.M. Van der Waal; B.G. Verheggen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

99 Caspofungin vs. caspofungin combined

✍ R. Strahm; S.L. Leib; J. Kummer; S. Zimmerli 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 98 KB

PIN16 COST-EFFECTIVENESS ANALYSIS OF MIC

✍ A Odeyemi; WM Hart; II Odeyemi; P Musingarimi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Liposomal amphotericin B in the treatmen

✍ W. Mills; R. Chopra; D. C. Linch; A. H. Goldstone 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 704 KB

Twenty-four hour continuous infusion of

✍ P. Hall; G. Kennedy; J. Morton; G. R. Hill; S. Durrant 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB